I scream, you scream, we all scream… for the medicine given to recovering cancer patients.
The Scientist reports that LactoPharma, (a “collaborative research venture between the University of Aukland, the New Zealand government, and the country’s largest dairy company, Fonterra Ltd.”) has created a therapeutic, strawberry-flavored ice cream called ReCharge.
ReCharge ice cream has gone through a string of taste-tests to ensure that the product satisfies the palette. However, one ingredient is a mandatory keeper: Lactoferrin, a protein found in milk that possesses the power to impede tumor growth and improve intestinal immune response. Because side effects of chemotherapy include the destruction of neutrophils (while blood cells) and intestinal cells, which often leads to infection and digestive problems, University of Auckland biologist Geoff Krissansen decided to test bovine lactoferrin on chemotherapy patients to see whether it could counter these side effects.
